Congenital methemoglobinemia. Report of a case

Methemoglobinemia is a condition in which there are high blood levels of methemoglobin. It may be congenital or acquired. The congenital form (which is rare) is the result of a defect in the methemoglobin reductase enzyme, dependent of the nicotinamide adenine dinucleotide phosphate reduced (NADPH)...

Full description

Bibliographic Details
Main Authors: Zárate Aspiros Romeo, Rosas Sumano Ana Beatriz, Sánchez Ramírez Alma Rosa
Format: Article
Language:Spanish
Published: Instituto Nacional de Pediatría 2014-07-01
Series:Acta Pediátrica de México
Subjects:
Online Access:http://ojs.actapediatrica.org.mx/index.php/APM/article/view/608
_version_ 1818514280862973952
author Zárate Aspiros Romeo
Rosas Sumano Ana Beatriz
Sánchez Ramírez Alma Rosa
author_facet Zárate Aspiros Romeo
Rosas Sumano Ana Beatriz
Sánchez Ramírez Alma Rosa
author_sort Zárate Aspiros Romeo
collection DOAJ
description Methemoglobinemia is a condition in which there are high blood levels of methemoglobin. It may be congenital or acquired. The congenital form (which is rare) is the result of a defect in the methemoglobin reductase enzyme, dependent of the nicotinamide adenine dinucleotide phosphate reduced (NADPH); it is also caused by hemoglobinopathies. Congenital methemoglobinemia type 2 constitutes 10% of all cases and is usually fatal in early life. Its main feature is progressive neurological deterioration associa- ted with mental retardation, microcephaly, opisthotonos, athetotic movements, and generalized hypertonia. We report the case of a newborn with cyanosis from birth in whom perinatal hypoxia, pulmonary disease, heart failure and sepsis were ruled out, hence methemoglobin levels were requested, which led to the diagnosis of congenital methemoglobinemia based on a methemoglobin of 29.6%. Methemoglobin values were investigated in his 2 years old brother, who was cyanotic and showed progressive psychomotor retardation from birth; his methemoglobin was 30%. We concluded that both patients had type 2 hereditary methemoglobinemia in view of the severe neu- rological disorders of the older brother. Treatment with ascorbic acid was initiated in both siblings, resulting in the disappearance of cyanosis in the newborn.
first_indexed 2024-12-11T00:13:34Z
format Article
id doaj.art-677e507d76224d5a83e645486f29328f
institution Directory Open Access Journal
issn 0186-2391
2395-8235
language Spanish
last_indexed 2024-12-11T00:13:34Z
publishDate 2014-07-01
publisher Instituto Nacional de Pediatría
record_format Article
series Acta Pediátrica de México
spelling doaj.art-677e507d76224d5a83e645486f29328f2022-12-22T01:28:03ZspaInstituto Nacional de PediatríaActa Pediátrica de México0186-23912395-82352014-07-01341394210.18233/APM34No1pp39-42610Congenital methemoglobinemia. Report of a caseZárate Aspiros Romeo0Rosas Sumano Ana BeatrizSánchez Ramírez Alma RosaActa Pediátrica de MéxicoMethemoglobinemia is a condition in which there are high blood levels of methemoglobin. It may be congenital or acquired. The congenital form (which is rare) is the result of a defect in the methemoglobin reductase enzyme, dependent of the nicotinamide adenine dinucleotide phosphate reduced (NADPH); it is also caused by hemoglobinopathies. Congenital methemoglobinemia type 2 constitutes 10% of all cases and is usually fatal in early life. Its main feature is progressive neurological deterioration associa- ted with mental retardation, microcephaly, opisthotonos, athetotic movements, and generalized hypertonia. We report the case of a newborn with cyanosis from birth in whom perinatal hypoxia, pulmonary disease, heart failure and sepsis were ruled out, hence methemoglobin levels were requested, which led to the diagnosis of congenital methemoglobinemia based on a methemoglobin of 29.6%. Methemoglobin values were investigated in his 2 years old brother, who was cyanotic and showed progressive psychomotor retardation from birth; his methemoglobin was 30%. We concluded that both patients had type 2 hereditary methemoglobinemia in view of the severe neu- rological disorders of the older brother. Treatment with ascorbic acid was initiated in both siblings, resulting in the disappearance of cyanosis in the newborn.http://ojs.actapediatrica.org.mx/index.php/APM/article/view/608Metahemoglobinemia congénitacianosismetahemoglobina reductosadeterioro neurológicoretraso mental
spellingShingle Zárate Aspiros Romeo
Rosas Sumano Ana Beatriz
Sánchez Ramírez Alma Rosa
Congenital methemoglobinemia. Report of a case
Acta Pediátrica de México
Metahemoglobinemia congénita
cianosis
metahemoglobina reductosa
deterioro neurológico
retraso mental
title Congenital methemoglobinemia. Report of a case
title_full Congenital methemoglobinemia. Report of a case
title_fullStr Congenital methemoglobinemia. Report of a case
title_full_unstemmed Congenital methemoglobinemia. Report of a case
title_short Congenital methemoglobinemia. Report of a case
title_sort congenital methemoglobinemia report of a case
topic Metahemoglobinemia congénita
cianosis
metahemoglobina reductosa
deterioro neurológico
retraso mental
url http://ojs.actapediatrica.org.mx/index.php/APM/article/view/608
work_keys_str_mv AT zarateaspirosromeo congenitalmethemoglobinemiareportofacase
AT rosassumanoanabeatriz congenitalmethemoglobinemiareportofacase
AT sanchezramirezalmarosa congenitalmethemoglobinemiareportofacase